SPAIN: Nozar buys 5% in Natraceutical, analysts forecasts bright
Spanish functional-foods maker Natraceutical said yesterday (9 October) that it sold a 5% stake to local real estate firm Nozar for EUR21.6m (US$27.15m), triggering a 15% jump in its share price to EUR1.93.
The move came as Spanish brokerage firm Ibersecurities updated Natraceutical's stock rating to "buy," saying that the company's future looks bright.
Natraceutical's president said the deal highlights "investors' confidence in our company's growth potential."
Nozar, which will take a seat on Natraceutical's board, is also expected to back Natracuetical's EUR61m upcoming share offer to finance its recent acquisition of Forte Pharma.
Natraceutical's recent international acquisitions and expansion efforts have created a "successful business model" ideally positioned to take advantage of the burgeoning global functional-ingredients market, which is growing 20% annually, Ibersecurities said.
Ibersecurities forecast that Natraceuticals will deliver operating profits of EUR14m this year, up 7-fold from EUR2m in 2005. Revenues are expected to increase 130% to EUR108m.
- It won't just be Unilever to push for Brexit hikes
- Price an underlying tension across European FMCG
- Danone's Q3 sales - what the analysts say
- Interview: UK trade body on Brexit's policy impact
- Interview: UK trade body on the impact of Brexit
- Nestle lowers outlook on "softer environment"
- UK announces "action plan" to drive food exports
- Farmers' groups slam Danone over non-GMO stance
- Kraft Heinz: Innovation more important than ever
- China "transition" drags on Danone Q3
- The Big 15: Strategies and Priorities of Top Packaged Food Players in Comparison
- Omega-3 in Food and Beverage:Time for a Reboot?
- Global Food Packaging: Innovating for Greater Convenience and Quality Image
- Packaged Food: Quarterly Statement Q3 2016
- Constellation Brands, Inc. (STZ) - Financial and Strategic SWOT Analysis Review